Epigenetics has flourished to become one of the most revolutionary areas of science over the past decade. Also, advances in the understanding of epigenetic processes have led to a burst in interest in this area as a potential source of new targets for the discovery of medicines. While the promise of epigenetics is significant, it also presents some interesting challenges right from the developmental to translational phase.
However, enough progress has been made that it is worthwhile highlighting some emerging themes in terms of drug discovery approach with respect to emerging targets, inhibitors, biomarkers and clinical success of epigenetics across various diseases. At the 2nd Annual Epigenetics Discovery Congress which will be held on 8-9 September, 2016 in London - UK, researchers, academics and industry professionals working in epigenetic research can avail an opportunity to explore the potential of epigenetics to contribute towards novel and existing therapeutics, current progress and trends in the inclusion of epigenetics in drug discovery and development.
Who will attend?
0 DAY EVENT
0 Hours of Networking
2nd Annual Epigenetics Discovery Congress
Accommodation is currently available at the London Heathrow Marriott Hotel at discounted rates from £149 including breakfast and taxes. To make your reservation, please click here before 26th August 2016, booking in advance is recommend as there are a limited number of room available at this rate (Please note that we do not authorise any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than me regarding your accommodation requirements for this event, please let me know immediately).